SCHEMBL4903734

SCHEMBL4903734

CCc1ccc(S(=O)(=O)N(CC)c2ccc(Oc3cccnc3)cc2)cc1C(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.50
ALDH1A1 P00352 2/20 0.48
MAPT P10636 2/20 0.48
TSHR P16473 2/20 0.48
TP53 P04637 1/20 0.48
RXFP1 Q9HBX9 1/20 0.48
KEAP1 Q14145 1/20 0.48
NFE2L2 Q16236 1/20 0.48
GRM2 Q14416 2/20 0.48
MCL1 Q07820 2/20 0.46
BCL2L1 Q07817 1/20 0.46
HPGD P15428 2/20 0.45
ALOX15 P16050 2/20 0.45
HSD17B10 Q99714 1/20 0.45
PTGES O14684 3/20 0.44
ALOX5 P09917 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
KDM4E B2RXH2 1/20 0.42
USP2 O75604 1/20 0.42
POLB P06746 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908278 0.91 ALDH1A1 (0.48) LMNAALDH1A1MAPTTSHRTP53
SCHEMBL4903975 0.90 LMNA (0.50) LMNAALDH1A1MAPTTSHRTP53
SCHEMBL4906440 0.90 LMNA (0.61) LMNAALDH1A1MAPTMCL1BCL2L1
SCHEMBL4904663 0.89 LMNA (0.52) LMNAALDH1A1MAPTTSHRMCL1
SCHEMBL4906379 0.86 GRM2 (0.47) LMNAALDH1A1MAPTTSHRTP53
SCHEMBL4898076 0.84 LMNA (0.58) LMNAALDH1A1MAPTTSHRMCL1
SCHEMBL4895733 0.84 LMNA (0.56) LMNAALDH1A1MAPTMCL1BCL2L1
SCHEMBL4903613 0.83 TP53 (0.48) LMNAALDH1A1MAPTTSHRTP53
SCHEMBL4900991 0.82 LMNA (0.51) LMNAALDH1A1MCL1BCL2L1HPGD
SCHEMBL4903163 0.81 LMNA (0.53) LMNAALDH1A1MAPTMCL1BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885MAPT 1786/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885MAPT 1786/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.